Upgrade to SI Premium - Free Trial

Carter's (CRI) PT Lowered to $100 at Monness, Crespi, Hardt

May 4, 2020 8:14 AM
Monness, Crespi, Hardt analyst Jim Cartier lowered the price target on Carter's (NYSE: CRI) to $100.00 (from $115.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles